Related Experiment Video
Updated: May 14, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy
1Department of General Medicine, College of Medicine, Taipei Medical University, Taiwan.
Insights
Peroxisome proliferator-activated receptors (PPARs) are crucial for managing energy and lipid balance in diabetes. This review explores their role in diabetic heart disease, inflammation, and cardiac electrical function.
Area of Science:
- Cardiovascular Science
- Metabolic Disease Research
- Molecular Biology
Background:
- Cardiovascular disease (CVD) is a major complication of diabetes mellitus (DM), characterized by chronic inflammation and impaired myocardial energy and lipid metabolism.
- Peroxisome proliferator-activated receptors (PPARs), a nuclear receptor superfamily, are key regulators of energy and lipid homeostasis.
- The three PPAR isoforms (α, γ, and δ) are expressed in the heart and influence myocardial metabolism, inflammation, and oxidative stress.
Purpose of the Study:
- To review the multifaceted roles of PPARs and their agonists in the context of diabetes mellitus (DM).
- To elucidate the impact of PPARs on diabetic cardiomyopathy, inflammation, and cardiac electrophysiology.
Main Methods:
- Literature review focusing on the roles of PPARs and their agonists in DM-related cardiovascular complications.
- Analysis of studies investigating PPAR expression and function in cardiac tissue under diabetic conditions.
- Synthesis of findings related to PPARs' effects on myocardial lipid metabolism, glucose homeostasis, inflammation, oxidative stress, and cardiac electrical activity.
Main Results:
- PPARs are integral to maintaining myocardial lipid and energy homeostasis, crucial for mitigating DM-induced cardiac dysfunction.
- PPAR activation demonstrates potential in modulating inflammation and oxidative stress, key contributors to diabetic cardiomyopathy.
- PPARs significantly influence cardiac electrical activity and may play a role in preventing or treating cardiac arrhythmias in diabetic patients.
Conclusions:
- PPARs represent a promising therapeutic target for managing diabetic cardiomyopathy and associated cardiovascular risks.
- Understanding PPAR regulation is vital for developing novel strategies to address the complex interplay between diabetes, inflammation, and heart disease.
- Further research into PPAR agonists could lead to improved treatments for diabetic cardiovascular complications, including arrhythmias.
Abstract:
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among patients with diabetes mellitus (DM). Chronic inflammation and derangement of myocardial energy and lipid homeostasis are common features of DM. The transcription factors of peroxisome proliferator-activated receptors (PPARs) belong to the nuclear receptor superfamily, which are important in regulating energy and lipid homeostasis. There are three PPAR isoforms, α, γ, and δ, and their roles have been increasingly recognized to be important in CVD. These three isoforms are expressed in the heart and play pivotal roles in myocardial lipid metabolism, as well as glucose and energy homeostasis, and contribute to extra metabolic roles with effects on inflammation and oxidative stress. Moreover, regulation of PPARs may have significant effects on cardiac electrical activity and arrhythmogenesis. This review describes the roles of PPARs and their agonists in DM cardiomyopathy, inflammation, and cardiac electrophysiology.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Peroxisomes
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Coronary Artery Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Diabetic Retinopathy

